Eli Lilly & Co. (LLY)

167.99 +1.10 (0.66%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/20 *Est.)
- M&A (3/31/19 *Est)
- M&A (3/31/20 *Est)

Latest Headlines

Form 4 ELI LILLY & Co For: Jul 06 Filed by: LILLY ENDOWMENT INC July 7, 2020 2:28 PM - SEC Filing U.S. signs $450 million contract with Regeneron for COVID-19 therapy July 7, 2020 8:02 AM - StreetInsider Form 4 ELI LILLY & Co For: Jul 05 Filed by: Pusey Leigh Ann July 6, 2020 4:50 PM - SEC Filing Form 4 Elanco Animal Health For: Jul 01 Filed by: Mason Racquel Harris July 6, 2020 4:20 PM - SEC Filing Form 4 Elanco Animal Health For: Jul 01 Filed by: Correia de Simas Jose Manuel July 6, 2020 4:11 PM - SEC Filing LEGAL DEADLINE ALERT—The Law Firm of Barbuto & Johansson, P.A. Reminds LOPE, R, ELAN and WFC Shareholders of Important Class Action Deadlines July 6, 2020 2:40 AM - Globe NewsWire Form 4 ELI LILLY & Co For: Jun 30 Filed by: LILLY ENDOWMENT INC July 1, 2020 11:18 AM - SEC Filing Form 4 ELI LILLY & Co For: Jun 26 Filed by: LILLY ENDOWMENT INC July 1, 2020 9:56 AM - SEC Filing Form 4 ELI LILLY & Co For: Jun 29 Filed by: LILLY ENDOWMENT INC June 30, 2020 3:12 PM - SEC Filing Form 4 ELI LILLY & Co For: Jun 26 Filed by: LILLY ENDOWMENT INC June 30, 2020 2:49 PM - SEC Filing AgBiome Secures Patent Protection for New Connate Product Line June 30, 2020 10:00 AM - PR NewsWire LEGAL DEADLINE ALERT—The Law Firm of Barbuto & Johansson, P.A. Reminds ELAN, FSCT, PRA and USO Shareholders of Important Class Action Deadlines June 29, 2020 9:12 PM - Globe NewsWire Central Indiana Racial Equity Fund Launches with more than $2.2 Million in Initial Commitments June 25, 2020 8:00 AM - PR NewsWire Lilly launches program about what people with diabetes should "Know Before the Low™" June 24, 2020 8:30 AM - PR NewsWire AgBiome Expands Biological Product Offerings with Second In-House Developed Fungicide, Theia June 23, 2020 10:00 AM - PR NewsWire Once-weekly Trulicity® (dulaglutide) demonstrates significantly higher adherence and more persistence compared to once-weekly semaglutide and exenatide injections June 19, 2020 8:37 PM - Globe NewsWire Form 4 ELI LILLY & Co For: Jun 18 Filed by: LILLY ENDOWMENT INC June 19, 2020 2:21 PM - SEC Filing Full results from EMPERIAL exercise ability trials presented June 19, 2020 12:25 PM - PR NewsWire Eli Lilly (LLY) PT Raised to $180 at BofA Securities June 19, 2020 9:25 AM - StreetInsider Form 4 ELI LILLY & Co For: Jun 17 Filed by: LILLY ENDOWMENT INC June 18, 2020 5:16 PM - SEC Filing Form 8-K Elanco Animal Health For: Jun 15 June 18, 2020 4:25 PM - SEC Filing ELAN Class Action Deadline: Barbuto & Johansson, P.A. Reminds Elanco Animal Health, Inc. Shareholders of Important Deadline in the Recently Filed Securities Class Action June 18, 2020 2:30 PM - Globe NewsWire Eli Lilly (LLY) PT Raised to $180 at Cowen June 18, 2020 9:52 AM - StreetInsider Form 4 ELI LILLY & Co For: Jun 16 Filed by: Zulueta Alfonso G June 18, 2020 9:36 AM - SEC Filing Eli Lilly & Co. (LLY) Initiates Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients June 18, 2020 8:05 AM - StreetInsider Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients June 18, 2020 8:00 AM - Globe NewsWire Form 4 ELI LILLY & Co For: Jun 16 Filed by: LILLY ENDOWMENT INC June 17, 2020 3:14 PM - SEC Filing Eli Lilly & Co. (LLY) Announces Emgality Demonstrates Reduction in Frequency, Duration, and Pain Severity in Patients with Episodic and Chronic Migraine June 17, 2020 6:46 AM - StreetInsider Emgality® Demonstrates Reduction in Frequency, Duration, and Pain Severity in Patients with Episodic and Chronic Migraine June 17, 2020 6:45 AM - PR NewsWire Eli Lilly (LLY) PT Raised to $166 at UBS June 17, 2020 5:39 AM - StreetInsider Form 11-K ELI LILLY & Co For: Dec 31 June 16, 2020 5:08 PM - SEC Filing Form 4 ELI LILLY & Co For: Jun 15 Filed by: TAI JACKSON P June 16, 2020 4:31 PM - SEC Filing Eli Lilly & Co. (LLY) Trades at High, Up 17% June 16, 2020 12:35 PM - StreetInsider Lilly's OVERCOME Study Reveals Less than 30 Percent of People Living with Migraine Take Recommended Prescription Medications June 16, 2020 11:00 AM - PR NewsWire Guggenheim Upgrades Eli Lilly (LLY) to Buy June 16, 2020 8:25 AM - StreetInsider Lilly (LLY) Announces Verzenio Significantly Reduced Risk of Cancer Returning in People with High Risk HR+, HER2- Early Breast Cancer June 16, 2020 6:46 AM - StreetInsider Verzenio® (abemaciclib) Significantly Reduced the Risk of Cancer Returning in People with High Risk HR+, HER2- Early Breast Cancer June 16, 2020 6:45 AM - PR NewsWire FDA approves Lyumjev™ (insulin lispro-aabc injection), Lilly's new rapid-acting insulin June 15, 2020 10:22 PM - PR NewsWire Lilly (LLY) Begins Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients June 15, 2020 6:45 AM - StreetInsider Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients June 15, 2020 6:45 AM - PR NewsWire Once-weekly Trulicity® (dulaglutide) demonstrates significantly higher adherence and more persistence compared to once-weekly semaglutide and exenatide injections June 13, 2020 11:15 AM - PR NewsWire Eli Lilly and Company Foundation Pledges $25 Million to Combat Racial Injustice June 13, 2020 11:00 AM - PR NewsWire Lilly (LLY) and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life June 12, 2020 3:47 PM - StreetInsider Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life June 12, 2020 3:46 PM - PR NewsWire Lilly (LLY) Highlights Evolution of Its Dermatology Portfolio at Annual AAD Meeting June 12, 2020 3:02 PM - StreetInsider Lilly Highlights the Evolution of Its Dermatology Portfolio at Annual American Academy of Dermatology Meeting (AAD) June 12, 2020 3:00 PM - PR NewsWire Lilly Partners with Indianapolis Recorder Newspaper, Radio One and WISH-TV for a Day of Solidarity Virtual Event June 12, 2020 11:03 AM - PR NewsWire Eli Lilly & Co. (LLY) said one of its antibody therapies could be authorized for COVID-19 treatment as early as September - Reuters June 10, 2020 3:40 PM - StreetInsider EULAR 2020: Lilly Shares New Data for OLUMIANT® in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) June 10, 2020 3:19 PM - Globe NewsWire S&P 500, Dow finish lower in volatile trade on dour Fed forecasts June 10, 2020 6:57 AM - StreetInsider Form 4 ELI LILLY & Co For: Jun 05 Filed by: Zulueta Alfonso G June 9, 2020 4:53 PM - SEC Filing First patient dose delivered for Lilly's tirzepatide cardiovascular outcomes trial June 9, 2020 6:45 AM - PR NewsWire Lilly to Participate in Goldman Sachs Global Healthcare Conference June 8, 2020 11:00 AM - PR NewsWire Elanco Animal Health (ELAN) Announces EC Approval of Pending Acquisition of Bayer Animal Health June 8, 2020 10:45 AM - StreetInsider Elanco Announces European Commission Approval of Pending Acquisition of Bayer Animal Health June 8, 2020 10:45 AM - BizWire Lilly (LLY) Announces Start of Phase 1 Study for its Second Potential COVID-19 Antibody Treatment June 8, 2020 7:16 AM - StreetInsider Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment June 8, 2020 7:15 AM - PR NewsWire Eli Lilly & Co. (LLY), Junshi Biosciences Report First Healthy Volunteer Dosing in Phase I Clinical Study of SARS-CoV-2 Neutralizing Antibody JS016 in China June 8, 2020 5:55 AM - StreetInsider Eli Lilly & Co. (LLY) option implied volatility flat at 27 June 8, 2020 5:32 AM - StreetInsider Junshi Biosciences Announces Dosing of First Healthy Volunteer in Phase I Clinical Study of SARS-CoV-2 Neutralizing Antibody JS016 in China June 7, 2020 11:31 AM - StreetInsider Junshi Biosciences Announces Dosing of First Healthy Volunteer in Phase I Clinical Study of SARS-CoV-2 Neutralizing Antibody JS016 in China June 7, 2020 11:30 AM - Globe NewsWire AstraZeneca contacted Gilead over potential megamerger: Bloomberg News June 7, 2020 4:21 AM - StreetInsider EULAR 2020: Lilly’s TALTZ® (ixekizumab) Continues to Show Robust and Consistent Efficacy in Psoriatic Arthritis June 5, 2020 6:09 PM - Globe NewsWire Form 4 Elanco Animal Health For: Jun 03 Filed by: Meer James M June 5, 2020 7:20 AM - SEC Filing Elanco to Participate in Goldman Sachs 41st Annual Global Healthcare Conference June 3, 2020 8:30 AM - BizWire EULAR 2020: Lilly Shares New Data for Olumiant® in Rheumatoid Arthritis and Systemic Lupus Erythematosus June 3, 2020 6:45 AM - PR NewsWire EULAR 2020: Lilly's Taltz® (ixekizumab) Continues to Show Robust and Consistent Efficacy in Psoriatic Arthritis June 3, 2020 6:45 AM - PR NewsWire Sorrento Therapeutics (SRNE) Targeting The Same Targets as LLY's Treatment Entering Human Testing June 2, 2020 7:26 AM - StreetInsider Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions June 2, 2020 7:10 AM - StreetInsider Eli Lilly & Co. (LLY) Could be the Beneficiary of Pfizer's (PFE) Ibrance Setback - Goldman Sachs June 1, 2020 7:56 AM - StreetInsider Eli Lilly & Co. (LLY) Reports First IL-17A Antagonist Granted FDA Approval for Treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA) June 1, 2020 6:47 AM - StreetInsider Lilly's Taltz® (ixekizumab) is the First IL-17A Antagonist to Receive U.S. FDA Approval for the Treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA) June 1, 2020 6:45 AM - PR NewsWire Lilly (LLY) Begins World's First Study of Potential COVID-19 Antibody Treatment in Humans June 1, 2020 6:33 AM - StreetInsider Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans June 1, 2020 6:30 AM - PR NewsWire Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma May 31, 2020 7:30 PM - PR NewsWire Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophag May 31, 2020 7:30 PM - PR NewsWire Lilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer May 29, 2020 9:07 PM - PR NewsWire Lilly Receives U.S. FDA Approval of TAUVID™ (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer's Disease May 28, 2020 7:17 PM - PR NewsWire Elanco Helps More Than 1.4 Million Households and 293 Communities Become More Food Secure, Nearly Tripling Goal May 28, 2020 8:30 AM - BizWire Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19 May 27, 2020 5:14 AM - StreetInsider Statement from Lilly Chairman and CEO Dave Ricks on New Part D Senior Savings Model May 26, 2020 5:51 PM - PR NewsWire Eli Lilly (LLY), Novo Nordisk (NVO) Sanofi (SNY) Back New Insulin Plan - Bloomberg Citing CMS Admin. Verma May 26, 2020 12:20 PM - StreetInsider Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences' COVID-19 Neutralizing Antibodies May 26, 2020 10:12 AM - StreetInsider Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibodies May 26, 2020 10:11 AM - StreetInsider Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibodies May 26, 2020 10:10 AM - Globe NewsWire Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarction May 26, 2020 8:00 AM - PR NewsWire Lilly (LLY) Announces Emgality Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine May 26, 2020 6:51 AM - StreetInsider Emgality® Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment Failure May 26, 2020 6:45 AM - PR NewsWire Form 8-K Elanco Animal Health For: May 21 May 22, 2020 4:31 PM - SEC Filing Form 4 ELI LILLY & Co For: May 18 Filed by: TAI JACKSON P May 20, 2020 9:09 AM - SEC Filing Results of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's Disease May 19, 2020 9:01 AM - PR NewsWire TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma May 13, 2020 7:30 PM - PR NewsWire Lilly Oncology Showcases Innovation in Cancer Research at ASCO 2020 May 13, 2020 5:00 PM - PR NewsWire Elanco to Participate in the Bank of America Securities Health Care Conference May 12, 2020 8:52 AM - BizWire Lilly Receives U.S. FDA Approval for Retevmo™ (selpercatinib), the First Therapy Specifically for Patients with Advanced RET-Driven Lung and Thyroid Cancers May 8, 2020 8:22 PM - PR NewsWire Lilly (LLY) reports higher investigational doses of Trulicity meaningfully reduced A1C and body weight in people with type 2 diabetes May 8, 2020 2:28 PM - StreetInsider Higher investigational doses of Trulicity® (dulaglutide) meaningfully reduced A1C and body weight in people with type 2 diabetes May 8, 2020 2:20 PM - PR NewsWire Form 10-Q Elanco Animal Health For: Mar 31 May 7, 2020 4:46 PM - SEC Filing Form 8-K Elanco Animal Health For: May 07 May 7, 2020 6:46 AM - SEC Filing Elanco Animal Health Reports 2020 First Quarter Results May 7, 2020 6:30 AM - BizWire Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in May 6, 2020 7:30 PM - PR NewsWire Lilly to Participate in UBS Virtual Global Healthcare Conference May 5, 2020 4:30 PM - PR NewsWire Form SD ELI LILLY & Co May 5, 2020 1:59 PM - SEC Filing Form 8-K ELI LILLY & Co For: May 04 May 5, 2020 1:47 PM - SEC Filing Eli Lilly & Co. (LLY) Declares $0.74 Quarterly Dividend; 1.9% Yield May 4, 2020 3:01 PM - StreetInsider Lilly Declares Second-Quarter 2020 Dividend May 4, 2020 3:00 PM - PR NewsWire Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 May 4, 2020 9:14 AM - StreetInsider Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 May 4, 2020 9:13 AM - Globe NewsWire Lilly (LLY) and Junshi Biosciences to Co-develop Antibody Therapies for Prevention and Treatment of COVID-19 May 4, 2020 8:03 AM - StreetInsider Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 May 4, 2020 8:00 AM - PR NewsWire Form 10-Q ELI LILLY & Co For: Mar 31 May 1, 2020 9:48 AM - SEC Filing Lilly to Participate in Bank of America Securities Health Care Conference April 30, 2020 4:30 PM - PR NewsWire Form 4 ELI LILLY & Co For: Apr 27 Filed by: LILLY ENDOWMENT INC April 28, 2020 12:21 PM - SEC Filing Merck sees $2.1 billion coronavirus hit to 2020 sales April 28, 2020 7:08 AM - StreetInsider Form 8-K ELI LILLY & Co For: Apr 24 April 28, 2020 6:18 AM - SEC Filing Form PX14A6G ELI LILLY & Co Filed by: SEIU Pension Plans Master Trust April 27, 2020 5:31 PM - SEC Filing Form 3 Elanco Animal Health For: Apr 20 Filed by: Correia de Simas Jose Manuel April 27, 2020 4:37 PM - SEC Filing Form 3 Elanco Animal Health For: Apr 20 Filed by: Mason Racquel Harris April 27, 2020 4:15 PM - SEC Filing Form 424B5 ELI LILLY & Co April 27, 2020 4:07 PM - SEC Filing Hibbett Announces Nomination of Jamere Jackson for Election to Its Board of Directors April 27, 2020 2:40 PM - BizWire Form 4 ELI LILLY & Co For: Apr 24 Filed by: LILLY ENDOWMENT INC April 27, 2020 2:36 PM - SEC Filing Form 4 ELI LILLY & Co For: Apr 23 Filed by: LILLY ENDOWMENT INC April 27, 2020 10:40 AM - SEC Filing Form FWP ELI LILLY & Co Filed by: ELI LILLY & Co April 24, 2020 5:16 PM - SEC Filing Form 424B5 ELI LILLY & Co April 24, 2020 8:50 AM - SEC Filing Eli Lilly (LLY) PT Raised to $185 at Cantor Fitzgerald April 24, 2020 6:34 AM - StreetInsider Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC April 23, 2020 7:50 PM - PR NewsWire Form 8-K ELI LILLY & Co For: Apr 23 April 23, 2020 8:03 AM - SEC Filing Eli Lilly lifts 2020 profit forecast; coronavirus fuels stockpiling of its medicines April 23, 2020 6:44 AM - StreetInsider Eli Lilly & Co. (LLY) Tops Q1 EPS by 27c, Offers FY Guidance April 23, 2020 6:27 AM - StreetInsider Lilly Reports Strong First-Quarter Financial Results, Adjusts EPS Guidance April 23, 2020 6:25 AM - PR NewsWire Options expected to have increasing volume: LLY UNP APD HSY CTXS DPZ April 23, 2020 5:22 AM - StreetInsider Form 4 ELI LILLY & Co For: Apr 20 Filed by: TAI JACKSON P April 22, 2020 11:29 AM - SEC Filing Eli Lilly (LLY) PT Raised to $165 at BofA Securities April 22, 2020 8:20 AM - StreetInsider Mizuho Securities Reiterates Neutral Rating on Eli Lilly (LLY) April 22, 2020 6:44 AM - StreetInsider UBS Downgrades Eli Lilly (LLY) to Neutral on Valuation April 20, 2020 4:38 PM - StreetInsider Form 8-K Elanco Animal Health For: Apr 20 April 20, 2020 8:43 AM - SEC Filing Elanco Expands Executive Team to Lead Company Post Bayer Animal Health Acquisition April 20, 2020 8:30 AM - BizWire Eli Lilly & Co. (LLY) calls active amid shares at record high April 17, 2020 11:28 AM - StreetInsider Form 4 ELI LILLY & Co For: Apr 14 Filed by: Shah Aarti S. April 16, 2020 11:23 AM - SEC Filing Lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® now available April 16, 2020 6:45 AM - PR NewsWire Form DEFA14A ELI LILLY & Co April 15, 2020 10:07 AM - SEC Filing Elanco Animal Health Submits Form CO to European Commission April 14, 2020 11:00 AM - BizWire Form 4 ELI LILLY & Co For: Apr 09 Filed by: LILLY ENDOWMENT INC April 13, 2020 2:44 PM - SEC Filing Eli Lilly & Co. (LLY) initiates Clinical Testing of Therapies for COVID-19 April 13, 2020 5:58 AM - StreetInsider Lilly Begins Clinical Testing of Therapies for COVID-19 April 10, 2020 5:12 PM - PR NewsWire Elanco, VetNOW Collaborate to Expand Access to Veterinary Care, Relieve Impact of COVID-19 April 9, 2020 8:00 AM - BizWire Morgan Stanley Downgrades Eli Lilly (LLY) to Equalweight April 9, 2020 4:51 AM - StreetInsider Form DEFA14A Elanco Animal Health April 8, 2020 4:40 PM - SEC Filing Form DEF 14A Elanco Animal Health For: May 21 April 8, 2020 4:36 PM - SEC Filing Form 4 ELI LILLY & Co For: Apr 07 Filed by: LILLY ENDOWMENT INC April 8, 2020 12:50 PM - SEC Filing Lilly Confirms Date and Conference Call for First-Quarter 2020 Financial Results Announcement April 8, 2020 6:30 AM - PR NewsWire Full Article List